H.C. Wainwright’s $641 target on VRTX

VRTX Vertex Pharmaceuticals

$515 → $641 (+24%) by Sep 2027

Buy · maintains · said Sep 22, 2026 · 12-month default horizon

Open: judged on the close on Sep 22, 2027

The article this target came from

Vertex stock price target maintained at $641 by H.C. Wainwright

Investing.com · Sep 22, 2026

H.C. Wainwright reiterated a Buy rating on Vertex shares (NASDAQ:VRTX) and maintained its $641.00 price target on Monday.

H.C. Wainwright’s track record → Vertex Pharmaceuticals →

A fact about what H.C. Wainwright published, as reported by Investing.com, not a recommendation from Dalsna Finance; H.C. Wainwright is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.